Immune thrombocytopenia: improving quality of life and patient outcomes
Immune thrombocytopenia (ITP) is an immune-mediated disorder characterized by a reduced platelet count and patients may develop bruising or mucosal bleeding. Since 2003, generic health-related quality of life (HRQoL) measures have been applied and ITP-specific ...
Patient Relat Outcome Meas . 2018 Nov 27;9:369–384. doi: 10.2147/PROM.S140932 Immune thrombocytopenia: improving quality of life and patient outcomes Patrick Trotter Patrick Trotter 1 Department of Surgery, University of Cambridge, Cambridge, UK 2 National Health Service Blood and Transplant, Organ Donation and Transplant Directorate, Bristol, UK Find articles by Patrick Trotter 1, 2 , Quentin A Hill Quentin A Hill 3 Department of Haematology, St James’s University Hospital, Leeds, UK, quentinhill@nhs.net Find articles by Quentin A Hill 3, ✉ Author information Article notes Copyright and Licen
related reading
- Going Up: What's Behind the Growth in IVIG Demandbstquarterly.com
- Lupus - Wikipediaen.wikipedia.org
- Acquired Hemophilia A - Symptoms, Causes, Treatment | NORDrarediseases.org
- Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov
- Thyrotoxic Periodic Paralysis(Archived) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Choosing to liveautoimmunegirlies.substack.com
- Overview of immune reconstitution inflammatory syndromesuptodate.com
- Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp
- Notionnotion.so
- Notionnotion.so
- Thymosin alpha 1: A comprehensive review of the literaturencbi.nlm.nih.gov